MedTrace Logo

Effects of Blood Flow Restriction Training in Rotator Cuff Related Shoulder Pain

NCT04834271 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2022-11-22

No results posted yet for this study

Summary

Blood flow restriction training is widespread in sport performance areas, where it has proven to be beneficial in strength and hypertrophy development. However, there are only few studies related to its effects on subjects with pathology, and currently, there is no recent clinical trial evaluating its effects on patients with RCRSP. We are aiming to define the potential benefits, acute and short-term effects of adding blood flow restriction to a low-load exercise training for patients with RCRSP.

Conditions

  • Subacromial Pain Syndrome

Interventions

OTHER

Side-lying external rotation exercise with a dumbbell

Side-lying external rotation exercise with a dumbbell (20-30% 1RM). 2 times per week during 4 weeks.

OTHER

Side-lying external rotation exercise with a dumbbell with 40% arterial occlusion pressure blood flow restriction

Side-lying external rotation exercise with a dumbbell (20-30% 1RM) with 40% arterial occlusion pressure blood flow restriction. 2 times per week during 4 weeks.

OTHER

Side-lying external rotation exercise with a dumbbell with 80% arterial occlusion pressure blood flow restriction

Side-lying external rotation exercise with a dumbbell (20-30% 1RM) with 80% arterial occlusion pressure blood flow restriction. 2 times per week during 4 weeks.

Sponsors & Collaborators

  • University of Alcala

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-03-01
Primary Completion
2021-12-01
Completion
2022-06-01

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04834271 on ClinicalTrials.gov